Sfoglia per Autore
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE MOLECULAR RESPONSE WITH ALPHA-INTERFERON AFTER TREATMENT DISCONTINUATION
2014 Latagliata, R; Romano, A; Mancini, M; Breccia, M; Carmosino, I; Vozella, F; Montagna, C; Volpicelli, P; Petrucci, L; Serao, A; Molica, M; Salaroli, A; Diverio, D; Tafuri, Agostino; Alimena, Giuliana
Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.
2014 Breccia, M; Molica, Matteo; Efficace, F; Minotti, C; Latagliata, R; Foa, Roberto; Lo Coco, F.
Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells.
2014 Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto
Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib
2015 Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; DE ANGELIS, Federico; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Alimena, Giuliana
Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy
2015 Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
2015 Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana
Improvement of bone marrow fibrosis with ruxolitinib: Will this finding change our perception of the drug?
2015 Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Alimena, Giuliana
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).
2015 Morano, Sg; Latagliata, R; Girmenia, C; Massaro, F; Berneschi, P; Guerriero, A; Giampaoletti, M; Sammarco, A; Annechini, G; Fama, A; DI ROCCO, Alice; Chistolini, Antonio; Micozzi, Alessandra; Molica, Matteo; Barberi, Walter; Minotti, C; Brunetti, Ga; Breccia, M; Cartoni, C; Capria, S; Rosa, G; Alimena, Giuliana; Foa, Roberto
Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response
2016 Latagliata, R.; Romano, A.; Mancini, M.; Breccia, Massimo; Carmosino, I.; Vozella, F.; Montagna, C.; Volpicelli, P.; De Angelis, F.; Petrucci, L.; Serrao, A.; Molica, M.; Salaroli, A.; Diverio, D.; Alimena, G.
Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization
2016 Molica, Matteo; Massaro, Fulvio; Annechini, Giorgia; Baldacci, Erminia; D'Elia, Gianna Maria; Rosati, Riccardo; Trisolini, Silvia Maria; Volpicelli, Paola; Foa, Roberto; Capria, Saveria
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up
2016 Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
2017 Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villivà, N; Celesti, F; Trawinska, Mm; Massaro, Fulvio; Di Veroli, A; Anaclerico, Barbara; Colafigli, Gioia; Molica, Matteo; Spadea, A; Petriccione, L; Cimino, Giuseppe; Latagliata, R.
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.
2017 Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M.
Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib.
2017 Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R.
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials
2017 Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life
2017 Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Foà, Robin
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events
2018 Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy
2018 Cicconi, Laura; Breccia, Massimo; Franceschini, Luca; Latagliata, Roberto; Molica, Matteo; Divona, Mariadomenica; Diverio, Daniela; Rizzo, Manuela; Ottone, Tiziana; Iaccarino, Licia; Alfonso, Valentina; Foa, Roberto; Teresa Voso, Maria; LO COCO, Francesco
Identification of Predictive Factors for Overall Survival at Baseline and during Azacitidine Treatment in High-Risk Myelodysplastic Syndromes Treated in the Clinical Practice
2018 Scalzulli, Emilia; Molica, Matteo; ALUNNI FEGATELLI, Danilo; Rizzo, Lorenzo; Roberto, Latagliata; Robin, Foà; Breccia, Massimo
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis
2018 Caocci, Giovanni; Mulas, Olga; Annunziata, Mario; Luciano, Luigiana; Bonifacio, Massimiliano; Orlandi, Ester Maria; Pregno, Patrizia; Galimberti, Sara; Russo Rossi, Antonella; Abruzzese, Elisabetta; Iurlo, Alessandra; Martino, Bruno; Sgherza, Nicola; Binotto, Gianni; Castagnetti, Fausto; Gozzini, Antonella; Fozza, Claudio; Bocchia, Monica; Sicuranza, Anna; Stagno, Fabio; Efficace, Fabio; Usala, Emilio; De Gregorio, Fiorenza; Scaffidi, Luigi; Elena, Chiara; Pirillo, Francesca; Baratè, Claudia; Trawinska, Malgorzata Monika; Cattaneo, Daniele; Labate, Claudia; Gugliotta, Gabriele; Molica, Matteo; Specchia, Giorgina; La Nasa, Giorgio; Foà, Robin; Breccia, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE MOLECULAR RESPONSE WITH ALPHA-INTERFERON AFTER TREATMENT DISCONTINUATION | 2014 | Latagliata, R; Romano, A; Mancini, M; Breccia, M; Carmosino, I; Vozella, F; Montagna, C; Volpicelli, P; Petrucci, L; Serao, A; Molica, M; Salaroli, A; Diverio, D; Tafuri, Agostino; Alimena, Giuliana | |
| Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid. | 2014 | Breccia, M; Molica, Matteo; Efficace, F; Minotti, C; Latagliata, R; Foa, Roberto; Lo Coco, F. | |
| Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocitic leukemia cells. | 2014 | Breccia, M; De Propris, Ms; Stefanizzi, Caterina; Raponi, Sara; Molica, Matteo; Colafigli, Gioia; Minotti, C; Latagliata, R; Diverio, D; Guarini, Anna; Foa, Roberto | |
| Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib | 2015 | Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; DE ANGELIS, Federico; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Alimena, Giuliana | |
| Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy | 2015 | Breccia, Massimo; Stefania de Propris, Maria; Molica, Matteo; Colafigli, Gioia; Minotti, Clara; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Lo Coco, Francesco; Foa, Roberto | |
| Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront | 2015 | Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana | |
| Improvement of bone marrow fibrosis with ruxolitinib: Will this finding change our perception of the drug? | 2015 | Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Alimena, Giuliana | |
| Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC). | 2015 | Morano, Sg; Latagliata, R; Girmenia, C; Massaro, F; Berneschi, P; Guerriero, A; Giampaoletti, M; Sammarco, A; Annechini, G; Fama, A; DI ROCCO, Alice; Chistolini, Antonio; Micozzi, Alessandra; Molica, Matteo; Barberi, Walter; Minotti, C; Brunetti, Ga; Breccia, M; Cartoni, C; Capria, S; Rosa, G; Alimena, Giuliana; Foa, Roberto | |
| Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response | 2016 | Latagliata, R.; Romano, A.; Mancini, M.; Breccia, Massimo; Carmosino, I.; Vozella, F.; Montagna, C.; Volpicelli, P.; De Angelis, F.; Petrucci, L.; Serrao, A.; Molica, M.; Salaroli, A.; Diverio, D.; Alimena, G. | |
| Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery Embolization | 2016 | Molica, Matteo; Massaro, Fulvio; Annechini, Giorgia; Baldacci, Erminia; D'Elia, Gianna Maria; Rosati, Riccardo; Trisolini, Silvia Maria; Volpicelli, Paola; Foa, Roberto; Capria, Saveria | |
| Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up | 2016 | Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto | |
| Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN. | 2017 | Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villivà, N; Celesti, F; Trawinska, Mm; Massaro, Fulvio; Di Veroli, A; Anaclerico, Barbara; Colafigli, Gioia; Molica, Matteo; Spadea, A; Petriccione, L; Cimino, Giuseppe; Latagliata, R. | |
| Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors. | 2017 | Molica, M; Canichella, M; Colafigli, G; Latagliata, R; Diverio, D; Alimena, G; Foà, R; Breccia, M. | |
| Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib. | 2017 | Molica, M; Breccia, M; Colafigli, G; Massaro, F; Quattrocchi, L; Mancini, M; Diverio, D; Latagliata, R; Foà, R. | |
| The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials | 2017 | Molica, Matteo; Canichella, Martina; Alunni Fegatelli, Danilo; Colafigli, Gioia; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life | 2017 | Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Foà, Robin | |
| Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events | 2018 | Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; Foà, Robin; Breccia, Massimo | |
| Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy | 2018 | Cicconi, Laura; Breccia, Massimo; Franceschini, Luca; Latagliata, Roberto; Molica, Matteo; Divona, Mariadomenica; Diverio, Daniela; Rizzo, Manuela; Ottone, Tiziana; Iaccarino, Licia; Alfonso, Valentina; Foa, Roberto; Teresa Voso, Maria; LO COCO, Francesco | |
| Identification of Predictive Factors for Overall Survival at Baseline and during Azacitidine Treatment in High-Risk Myelodysplastic Syndromes Treated in the Clinical Practice | 2018 | Scalzulli, Emilia; Molica, Matteo; ALUNNI FEGATELLI, Danilo; Rizzo, Lorenzo; Roberto, Latagliata; Robin, Foà; Breccia, Massimo | |
| Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis | 2018 | Caocci, Giovanni; Mulas, Olga; Annunziata, Mario; Luciano, Luigiana; Bonifacio, Massimiliano; Orlandi, Ester Maria; Pregno, Patrizia; Galimberti, Sara; Russo Rossi, Antonella; Abruzzese, Elisabetta; Iurlo, Alessandra; Martino, Bruno; Sgherza, Nicola; Binotto, Gianni; Castagnetti, Fausto; Gozzini, Antonella; Fozza, Claudio; Bocchia, Monica; Sicuranza, Anna; Stagno, Fabio; Efficace, Fabio; Usala, Emilio; De Gregorio, Fiorenza; Scaffidi, Luigi; Elena, Chiara; Pirillo, Francesca; Baratè, Claudia; Trawinska, Malgorzata Monika; Cattaneo, Daniele; Labate, Claudia; Gugliotta, Gabriele; Molica, Matteo; Specchia, Giorgina; La Nasa, Giorgio; Foà, Robin; Breccia, Massimo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile